LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 13

Search options

  1. Article ; Online: Rapidly progressive dementia with focal symptoms: when to suspect Creutzfeldt-Jakob disease?

    Sánchez-Soblechero, Antonio / Grandas, Francisco / Olazarán, Javier

    Acta neurologica Belgica

    2023  Volume 124, Issue 1, Page(s) 351–354

    MeSH term(s) Humans ; Creutzfeldt-Jakob Syndrome/diagnosis ; Creutzfeldt-Jakob Syndrome/diagnostic imaging ; 14-3-3 Proteins/metabolism
    Chemical Substances 14-3-3 Proteins
    Language English
    Publishing date 2023-07-14
    Publishing country Italy
    Document type Letter
    ZDB-ID 127315-2
    ISSN 2240-2993 ; 0300-9009
    ISSN (online) 2240-2993
    ISSN 0300-9009
    DOI 10.1007/s13760-023-02332-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Translating NIA-AA criteria into usual practice: Report from the ReDeMa Project.

    Sánchez-Soblechero, Antonio / Berbel, Angel / Villarejo, Alberto / Palmí-Cortés, Itziar / Vieira, Alba / Gil-Moreno, María José / Fernández, Cristina / Martín-Montes, Ãngel / Carreras, María Teresa / Fernández, Yolanda / Puertas, Carolina / Blanco-Palmero, Victor / Llamas, Sara / González-Sánchez, Marta / Lapeña, Teresa / de Luis, Pilar / Manzano, Sagrario / Olazarán, Javier

    Alzheimer's & dementia (New York, N. Y.)

    2024  Volume 10, Issue 1, Page(s) e12451

    Abstract: Introduction: Biomarker-informed criteria were proposed for the diagnosis of Alzheimer's disease (AD) by the National Institute on Aging and the Alzheimer's Association (NIA-AA) in 2011; however, the adequacy of this criteria has not been sufficiently ... ...

    Abstract Introduction: Biomarker-informed criteria were proposed for the diagnosis of Alzheimer's disease (AD) by the National Institute on Aging and the Alzheimer's Association (NIA-AA) in 2011; however, the adequacy of this criteria has not been sufficiently evaluated.
    Methods: ReDeMa (
    Results: A total of 233 patients were analyzed (mean age 70 years, 50% women, 73% AD). The diagnostic language was modified significantly, with a majority assumption of NIA-AA definitions (69%). Confidence in diagnosis increased from 70% to 92% (
    Discussion: The NIA-AA criteria are adequate and utile for usual practice in memory and neurology clinics, improving diagnostic confidence and significantly modifying patient management.
    Highlights: Alzheimer's disease (AD) cerebrospinal fluid (CSF) biomarkers increase diagnostic certainty regardless of the neurologist.AD CSF biomarkers lead to changes in disease management .Biomarker-enriched, 2011 NIA-AA diagnostic criteria are adequate for usual practice.
    Language English
    Publishing date 2024-03-18
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2832891-7
    ISSN 2352-8737 ; 2352-8737
    ISSN (online) 2352-8737
    ISSN 2352-8737
    DOI 10.1002/trc2.12451
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Where Should I Draw the Line: PET-Driven, Data-Driven, or Manufacturer Cut-Off?

    Sánchez-Soblechero, Antonio / López-García, Sara / Lage, Carmen / Fernández-Matarrubia, Marta / Irure, Juan / López-Hoyos, Marcos / Jiménez-Bonilla, Julio / Quirce, Remedios / de Arcocha-Torres, María / Cuenca-Vera, Oriana / Martín-Arroyo, Juan / Martínez-Dubarbie, Francisco / Pozueta, Ana / García-Martínez, María / Infante, Jon / Sánchez-Juan, Pascual / Rodríguez-Rodríguez, Eloy

    Journal of Alzheimer's disease : JAD

    2024  Volume 98, Issue 3, Page(s) 957–967

    Abstract: Background: The optimal cut-off for Alzheimer's disease (AD) CSF biomarkers remains controversial.: Objective: To analyze the performance of cut-off points standardized by three methods: one that optimized the agreement between 11C-Pittsburgh ... ...

    Abstract Background: The optimal cut-off for Alzheimer's disease (AD) CSF biomarkers remains controversial.
    Objective: To analyze the performance of cut-off points standardized by three methods: one that optimized the agreement between 11C-Pittsburgh compound B PET (a-PET) and CSF biomarkers (Aβ1-42, pTau, tTau, and Aβ1-42/Aβ1-40 ratio) in our population, called PET-driven; an unbiased cut-off using data from a healthy research cohort, called data-driven, and that provided by the manufacturer. We also compare changes in ATN classification.
    Methods: CSF biomarkers measured by the LUMIPULSE G600II platform and qualitative visualization of amyloid positron emission tomography (a-PET) were performed in all the patients. We established a cut-off for each single biomarker and Aβ1-42/Aβ1-40 ratio that optimized their agreement with a-PET using ROC curves. Sensitivity, Specificity, and Overall Percent of Agreement are assessed using a-PET or clinical diagnosis as gold standard for every cut-off. Also, we established a data-driven cut-off from our cognitively unimpaired cohort. We then analyzed changes in ATN classification.
    Results: One hundred and ten patients were recruited. Sixty-six (60%) were a-PET positive. PET-driven cut-offs were: pTau > 57, tTau > 362.62, Aβ1-42/Aβ1-40 < 0.069. For a single biomarker, pTau showed the highest accuracy (AUC 0.926). New PET-driven cut-offs classified patients similarly to manufacturer cut-offs (only two patients changed). However, 20 patients (18%) changed when data-driven cut-offs were used.
    Conclusions: We established our sample's best CSF biomarkers cut-offs using a-PET as the gold standard. These cut-offs categorize better symptomatic subjects than data-driven in ATN classification, but they are very similar to the manufacturer's.
    MeSH term(s) Humans ; Amyloid beta-Peptides ; tau Proteins ; Alzheimer Disease/diagnostic imaging ; Positron-Emission Tomography ; Biomarkers ; Peptide Fragments
    Chemical Substances Amyloid beta-Peptides ; tau Proteins ; Biomarkers ; Peptide Fragments
    Language English
    Publishing date 2024-03-15
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 1440127-7
    ISSN 1875-8908 ; 1387-2877
    ISSN (online) 1875-8908
    ISSN 1387-2877
    DOI 10.3233/JAD-230678
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Bilateral intracerebral hemorrhage as a presentation of central nervous system vasculitis in a patient with dermatomyositis.

    Sánchez-Soblechero, Antonio / López-Anguita, Sergio / Díaz-Otero, Fernando / Vázquez Alen, Pilar

    eNeurologicalSci

    2019  Volume 15, Page(s) 100181

    Language English
    Publishing date 2019-05-29
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 2838045-9
    ISSN 2405-6502 ; 2405-6502
    ISSN (online) 2405-6502
    ISSN 2405-6502
    DOI 10.1016/j.ensci.2019.01.005
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Upper trunk brachial plexopathy as a consequence of prone positioning due to SARS-CoV-2 acute respiratory distress syndrome.

    Sánchez-Soblechero, Antonio / García, Cristina Ausín / Sáez Ansotegui, Aiala / Fernández-Lorente, José / Catalina-Álvarez, Irene / Grandas, Francisco / Muñoz-Blanco, José Luis

    Muscle & nerve

    2020  Volume 62, Issue 5, Page(s) E76–E78

    MeSH term(s) Aged ; Brachial Plexus Neuropathies/etiology ; COVID-19/complications ; Humans ; Male ; Muscle Weakness/etiology ; Patient Positioning/adverse effects ; Prone Position ; Treatment Outcome
    Keywords covid19
    Language English
    Publishing date 2020-09-10
    Publishing country United States
    Document type Case Reports ; Letter
    ZDB-ID 438353-9
    ISSN 1097-4598 ; 0148-639X
    ISSN (online) 1097-4598
    ISSN 0148-639X
    DOI 10.1002/mus.27055
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Evaluation of the concomitant use of prophylactic treatments in patients with migraine under anti-calcitonin gene-related peptide therapies: The PREVENAC study.

    Gago-Veiga, Ana Beatriz / Lopez-Alcaide, Noelia / Quintas, Sonia / Fernández Lázaro, Iris / Casas-Limón, Javier / Calle, Carlos / Latorre, Germán / González-García, Nuria / Porta-Etessam, Jesús / Rodriguez-Vico, Jaime / Jaimes, Alex / Gómez García, Andrea / García-Azorín, David / Guerrero-Peral, Ángel Luis / Sierra, Álvaro / Lozano Ros, Alberto / Sánchez-Soblechero, Antonio / Díaz-de-Teran, Javier / Membrilla, Javier A /
    Treviño, Cristina / Gonzalez-Martinez, Alicia

    European journal of neurology

    2024  Volume 31, Issue 5, Page(s) e16215

    Abstract: Background and purpose: Anti-calcitonin gene-related peptide (CGRP) therapies are recent preventive therapies approved for both episodic and chronic migraine. One of the measures of effectiveness is the withdrawal of other preventive treatments. The ... ...

    Abstract Background and purpose: Anti-calcitonin gene-related peptide (CGRP) therapies are recent preventive therapies approved for both episodic and chronic migraine. One of the measures of effectiveness is the withdrawal of other preventive treatments. The objective of this study is to quantify the impact of anti-CGRP drugs in concomitant preventive treatment in patients with migraine.
    Methods: This was an observational, retrospective, multicenter cohort study with patients from nine national headache units. Patients with migraine undergoing treatment for at least 6 months with anti-CGRP antibodies, who were initially associated with some preventive treatment (oral and/or onabotulinumtoxinA) were included. Demographic and clinical variables were collected, as well as variables related to headache. Differences according to withdrawal or nonwithdrawal were evaluated.
    Results: A total of 408 patients were included, 86.52% women, 48.79 (SD = 1.46) years old. Preventive treatment was withdrawn in 43.87% (179/408), 20.83% partially and 23.04% totally. In 27.45% (112/408), it was maintained exclusively due to comorbidity and in 28.6% (117/408) due to partial efficacy. The most frequent time of withdrawal was between 3 and 5 months after the start of treatment. The baseline characteristics associated with nonwithdrawal were comorbidities: insomnia, hypertension and obesity, chronic migraine, and medication overuse. In the multivariate analysis, the absence of high blood pressure, a greater number of preventive treatments at the start, and a lower number of migraine days/month after anti-CGRP treatment were independently associated with withdrawal of the treatment (p < 0.05).
    Conclusions: Anti-CGRP antibodies allow the withdrawal of associated preventive treatment in a significant percentage of patients, which supports its effectiveness in real-life conditions.
    MeSH term(s) Humans ; Female ; Infant ; Male ; Calcitonin Gene-Related Peptide/therapeutic use ; Retrospective Studies ; Cohort Studies ; Migraine Disorders/drug therapy ; Migraine Disorders/prevention & control ; Headache
    Chemical Substances Calcitonin Gene-Related Peptide (JHB2QIZ69Z)
    Language English
    Publishing date 2024-02-07
    Publishing country England
    Document type Observational Study ; Multicenter Study ; Journal Article
    ZDB-ID 1280785-0
    ISSN 1468-1331 ; 1351-5101 ; 1471-0552
    ISSN (online) 1468-1331
    ISSN 1351-5101 ; 1471-0552
    DOI 10.1111/ene.16215
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Pathological Correlations of Neuropsychiatric Symptoms in Institutionalized People with Dementia.

    Esteban de Antonio, Ester / López-Álvarez, Jorge / Rábano, Alberto / Agüera-Ortiz, Luis / Sánchez-Soblechero, Antonio / Amaya, Laura / Portela, Sofía / Cátedra, Carlos / Olazarán, Javier

    Journal of Alzheimer's disease : JAD

    2020  Volume 78, Issue 4, Page(s) 1731–1741

    Abstract: Background: Comprehensive clinicopathological studies of neuropsychiatric symptoms (NPS) in dementia are lacking.: Objective: To describe the pathological correlations of NPS in a sample of institutionalized people with dementia.: Methods: We ... ...

    Abstract Background: Comprehensive clinicopathological studies of neuropsychiatric symptoms (NPS) in dementia are lacking.
    Objective: To describe the pathological correlations of NPS in a sample of institutionalized people with dementia.
    Methods: We studied 59 people who were consecutively admitted to a nursing home and donated their brain. Correlations between pathological variables and NPS upon admission (n = 59) and at one-year follow-up assessment (n = 46) were explored and confirmed using bivariate and multivariate statistical methods.
    Results: Mean (SD) age at admission was 83.2 (6.4) years and mean (SD) age at demise was 85.4 (6.6); 73% of the subjects were female and 98% presented advanced dementia. The most frequent etiological diagnosis was Alzheimer's disease (AD; 74.6% clinical diagnosis, 67.8% pathological diagnosis). The pathological diagnosis of AD was associated with aggression (β est 0.31), depression (β est 0.31), anxiety (β est 0.38), and irritability (β est 0.28). Tau stage correlated with aggressive symptoms (β est 0.32) and anxiety (βest 0.33). Coexistence of AD and Lewy body pathology was associated with depression (β est 0.32), while argyrophilic grains were associated with eating symptoms (β est 0.29). Predictive models were achieved for apathy, including cognitive performance, basal ganglia ischemic lesions, and sex as predictors (R2 0.38) and for sleep disorders, including pathological diagnosis of AD and age at demise (R2 0.18) (all p-values <0.05, unadjusted).
    Conclusion: AD was the main pathological substrate of NPS in our sample of very elderly people with advanced dementia. However, correlations were mild, supporting a model of focal/asymmetric rather than diffuse brain damage, along with relevance of environmental and other personal factors, in the genesis of those symptoms.
    MeSH term(s) Aged ; Aged, 80 and over ; Aggression ; Alzheimer Disease/pathology ; Alzheimer Disease/physiopathology ; Alzheimer Disease/psychology ; Anxiety/pathology ; Anxiety/psychology ; Apathy ; Brain/pathology ; Delusions/pathology ; Delusions/psychology ; Dementia/pathology ; Dementia/physiopathology ; Dementia/psychology ; Dementia, Vascular/pathology ; Dementia, Vascular/physiopathology ; Dementia, Vascular/psychology ; Depression/pathology ; Depression/psychology ; Female ; Hallucinations/pathology ; Hallucinations/psychology ; Humans ; Irritable Mood ; Lewy Body Disease/pathology ; Lewy Body Disease/physiopathology ; Lewy Body Disease/psychology ; Male ; Plaque, Amyloid/pathology
    Language English
    Publishing date 2020-11-13
    Publishing country Netherlands
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1440127-7
    ISSN 1875-8908 ; 1387-2877
    ISSN (online) 1875-8908
    ISSN 1387-2877
    DOI 10.3233/JAD-200600
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Acute Stroke Care during the COVID-19 Pandemic: Reduction in the Number of Admissions of Elderly Patients and Increase in Prehospital Delays.

    Velilla-Alonso, Gabriel / García-Pastor, Andrés / Rodríguez-López, Ángela / Gómez-Roldós, Ana / Sánchez-Soblechero, Antonio / Amaya-Pascasio, Laura / Díaz-Otero, Fernando / Fernández-Bullido, Yolanda / Iglesias-Mohedano, Ana María / Vázquez-Alén, Pilar / Vales-Montero, Marta / Gil-Núñez, Antonio-Carmelo

    Cerebrovascular diseases (Basel, Switzerland)

    2021  Volume 50, Issue 3, Page(s) 310–316

    Abstract: Introduction: We analyzed whether the coronavirus disease 2019 (COVID-19) crisis affected acute stroke care in our center during the first 2 months of lockdown in Spain.: Methods: This is a single-center, retrospective study. We collected demographic, ...

    Abstract Introduction: We analyzed whether the coronavirus disease 2019 (COVID-19) crisis affected acute stroke care in our center during the first 2 months of lockdown in Spain.
    Methods: This is a single-center, retrospective study. We collected demographic, clinical, and radiological data; time course; and treatment of patients meeting the stroke unit admission criteria from March 14 to May 14, 2020 (COVID-19 period group). Data were compared with the same period in 2019 (pre-COVID-19 period group).
    Results: 195 patients were analyzed; 83 in the COVID-19 period group, resulting in a 26% decline of acute strokes and transient ischemic attacks (TIAs) admitted to our center compared with the previous year (p = 0.038). Ten patients (12%) tested positive for PCR SARS-CoV-2. The proportion of patients aged 65 years and over was lower in the COVID-19 period group (53 vs. 68.8%, p = 0.025). During the pandemic period, analyzed patients were more frequently smokers (27.7 vs. 10.7%, p = 0.002) and had less frequently history of prior stroke (13.3 vs. 25%, p = 0.043) or atrial fibrillation (9.6 vs. 25%, p = 0.006). ASPECTS score was lower (9 [7-10] vs. 10 [8-10], p = 0.032), NIHSS score was slightly higher (5 [2-14] vs. 4 [2-8], p = 0.122), onset-to-door time was higher (304 [93-760] vs. 197 [91.25-645] min, p = 0.104), and a lower proportion arrived within 4.5 h from onset of symptoms (43.4 vs. 58%, p = 0.043) during the CO-VID-19 period. There were no differences between proportion of patients receiving recanalization treatment (intravenous thrombolysis and/or mechanical thrombectomy) and in-hospital delays.
    Conclusion: We observed a reduction in the number of acute strokes and TIAs admitted during the COVID-19 period. This drop affected especially elderly patients, and despite a delay in their arrival to the emergency department, the proportion of patients treated with recanalization therapies was preserved.
    MeSH term(s) Aged ; Aged, 80 and over ; Aging ; Brain Ischemia/diagnosis ; COVID-19/complications ; COVID-19/prevention & control ; Emergency Service, Hospital/statistics & numerical data ; Female ; Humans ; Ischemic Attack, Transient/therapy ; Male ; Middle Aged ; SARS-CoV-2/pathogenicity ; Stroke/diagnosis ; Stroke/etiology ; Stroke/therapy ; Thrombolytic Therapy/methods ; Time-to-Treatment
    Language English
    Publishing date 2021-03-17
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 1069462-6
    ISSN 1421-9786 ; 1015-9770
    ISSN (online) 1421-9786
    ISSN 1015-9770
    DOI 10.1159/000514140
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Upper trunk brachial plexopathy as a consequence of prone positioning due to SARS-CoV-2 acute respiratory distress syndrome

    Sánchez-Soblechero, Antonio / García, Cristina Ausín / Sáez Ansotegui, Aiala / Fernández-Lorente, José / Catalina-Álvarez, Irene / Grandas, Francisco / Muñoz-Blanco, José Luis

    Muscle nerve

    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #739633
    Database COVID19

    Kategorien

  10. Article ; Online: Upper trunk brachial plexopathy as a consequence of prone positioning due to SARS‐CoV ‐2 acute respiratory distress syndrome

    Sánchez‐Soblechero, Antonio / García, Cristina Ausín / Sáez Ansotegui, Aiala / Fernández‐Lorente, José / Catalina‐Álvarez, Irene / Grandas, Francisco / Muñoz‐Blanco, José Luis

    Muscle & Nerve ; ISSN 0148-639X 1097-4598

    2020  

    Keywords Physiology (medical) ; Physiology ; Cellular and Molecular Neuroscience ; Clinical Neurology ; covid19
    Language English
    Publisher Wiley
    Publishing country us
    Document type Article ; Online
    DOI 10.1002/mus.27055
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top